Literature DB >> 25765248

Increased 24-hour ad libitum food intake is associated with lower plasma irisin concentrations the following morning in adult humans.

Mathias Schlögl1, Paolo Piaggi2, Susanne B Votruba2, Mary Walter3, Jonathan Krakoff2, Marie S Thearle2.   

Abstract

BACKGROUND: The relationship between food intake and irisin concentrations in humans is unclear.
OBJECTIVES: To determine whether the previous day's intake impacts fasting plasma irisin concentrations, or whether fasting irisin concentrations associate with subsequent ad libitum food intake.
METHODS: Sixty-six nondiabetic adults (42 men) were admitted for a study of the determinants of energy intake. After 6 days of a weight maintaining diet, ad libitum energy intake over 3 days was assessed using a vending machine paradigm. Fasting plasma irisin concentrations were measured on the morning of the second day of the vending period.
RESULTS: There were no correlations between irisin and demographic or anthropometric parameters. On day 1, subjects consumed 144 ± 52% of weight maintaining energy needs. Every additional 500 kcal consumed on day 1 associated with a 3.4% lower irisin concentration the following morning (95% CI -6.2, -0.4%, p = 0.01; adjusted for age, sex and race). If energy intake was expressed as a percentage of weight maintaining energy needs, every 10% increase associated with a 1.9% lower irisin concentration (95% CI -3.7, -0.1%; adjusted p = 0.02). A 100 kcal increase in carbohydrate or fat consumption associated with a 1.3% (95% CI -2.5, -0.1%, p = 0.01) and a 0.6% (95% CI -1.1, -0.0%, p = 0.02) lower irisin concentration, respectively. There was no association between fasting irisin concentrations and subsequent energy intake on day 2 (r = 0.19, p = 0.1).
CONCLUSIONS: Higher ad libitum 24 h energy intake was associated with lower fasting irisin concentrations the following morning, but fasting irisin concentrations did not predict subsequent energy intake. The decrease in irisin concentrations with increased energy intake is consistent with the detrimental metabolic effects of overeating. Published by Elsevier Ltd.

Entities:  

Keywords:  Ad libitum food intake; Irisin

Mesh:

Substances:

Year:  2015        PMID: 25765248      PMCID: PMC4410111          DOI: 10.1016/j.appet.2015.03.003

Source DB:  PubMed          Journal:  Appetite        ISSN: 0195-6663            Impact factor:   3.868


  49 in total

1.  Body composition and appetite: fat-free mass (but not fat mass or BMI) is positively associated with self-determined meal size and daily energy intake in humans.

Authors:  John E Blundell; Phillipa Caudwell; Catherine Gibbons; Mark Hopkins; Erik Näslund; Neil A King; Graham Finlayson
Journal:  Br J Nutr       Date:  2011-07-07       Impact factor: 3.718

2.  Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running.

Authors:  Suleyman Aydin; Suna Aydin; Tuncay Kuloglu; Musa Yilmaz; Mehmet Kalayci; Ibrahim Sahin; Demet Cicek
Journal:  Peptides       Date:  2013-10-01       Impact factor: 3.750

3.  Body fat distribution and energy metabolism in obese men and women.

Authors:  P A Tataranni; D E Larson; E Ravussin
Journal:  J Am Coll Nutr       Date:  1994-12       Impact factor: 3.169

4.  Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype.

Authors:  Pavel Flachs; Martin Rossmeisl; Ondrej Kuda; Jan Kopecky
Journal:  Biochim Biophys Acta       Date:  2013-02-20

5.  Lower circulating irisin is associated with type 2 diabetes mellitus.

Authors:  Jian-Jun Liu; Melvin D S Wong; Wan Ching Toy; Clara S H Tan; Sylvia Liu; Xiao Wei Ng; Subramaniam Tavintharan; Chee Fang Sum; Su Chi Lim
Journal:  J Diabetes Complications       Date:  2013-04-22       Impact factor: 2.852

6.  Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Zacharias G Saridakis; Georgios Kynigopoulos; Elpida C Skouvaklidou; Dimitrios Molyvas; Maria F Vasiloglou; Aggeliki Apostolou; Thomai Karagiozoglou-Lampoudi; Aikaterina Siopi; Vassilis Mougios; Panagiotis Chatzistavridis; Grigorios Panagiotou; Andreas Filippaios; Sideris Delaroudis; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

Review 7.  Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease.

Authors:  Deborah M Muoio; Timothy R Koves
Journal:  Appl Physiol Nutr Metab       Date:  2007-10       Impact factor: 2.665

8.  A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.

Authors:  Pontus Boström; Jun Wu; Mark P Jedrychowski; Anisha Korde; Li Ye; James C Lo; Kyle A Rasbach; Elisabeth Almer Boström; Jang Hyun Choi; Jonathan Z Long; Shingo Kajimura; Maria Cristina Zingaretti; Birgitte F Vind; Hua Tu; Saverio Cinti; Kurt Højlund; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

9.  Is irisin a human exercise gene?

Authors:  James A Timmons; Keith Baar; Peter K Davidsen; Philip J Atherton
Journal:  Nature       Date:  2012-08-30       Impact factor: 69.504

10.  Body composition and energy expenditure predict ad-libitum food and macronutrient intake in humans.

Authors:  C M Weise; M G Hohenadel; J Krakoff; S B Votruba
Journal:  Int J Obes (Lond)       Date:  2013-05-23       Impact factor: 5.095

View more
  8 in total

1.  A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood.

Authors:  Pauline Teuffel; Miriam Goebel-Stengel; Tobias Hofmann; Philip Prinz; Sophie Scharner; Jan L Körner; Carsten Grötzinger; Matthias Rose; Burghard F Klapp; Andreas Stengel
Journal:  J Vis Exp       Date:  2016-04-28       Impact factor: 1.355

Review 2.  Irisin in metabolic diseases.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Zoe A Efstathiadou; Polyzois Makras; Nikolaos Perakakis; Jannis Kountouras; Christos S Mantzoros
Journal:  Endocrine       Date:  2017-11-23       Impact factor: 3.633

Review 3.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

4.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

Review 5.  Pathophysiology of Non Alcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Amalia Gastaldelli; Eleni Rebelos; Elisabetta Bugianesi; Piergiorgio Messa; Luca Miele; Gianluca Svegliati-Baroni; Luca Valenti; Ferruccio Bonino
Journal:  Int J Mol Sci       Date:  2016-12-11       Impact factor: 5.923

6.  Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial.

Authors:  Alberto R Osella; Graziana Colaianni; Mario Correale; Pasqua L Pesole; Irene Bruno; Claudia Buongiorno; Valentina Deflorio; Carla M Leone; Silvia Concetta Colucci; Maria Grano; Gianluigi Giannelli
Journal:  Nutrients       Date:  2018-06-28       Impact factor: 5.717

7.  Increased FNDC5 is associated with insulin resistance in high fat-fed mice.

Authors:  Brianne L Guilford; Jake C Parson; Caleb W Grote; Stephanie N Vick; Janelle M Ryals; Douglas E Wright
Journal:  Physiol Rep       Date:  2017-07

8.  Effects of Christian Orthodox Fasting Versus Time-Restricted Eating on Plasma Irisin Concentrations Among Overweight Metabolically Healthy Individuals.

Authors:  Spyridon N Karras; Theocharis Koufakis; Lilian Adamidou; Georgios Dimakopoulos; Paraskevi Karalazou; Katerina Thisiadou; Kali Makedou; Kalliopi Kotsa
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.